HOME › Analyst Briefings › Analyst Briefing Presentation on the “Lung Cancer Drugs Market in G7 Countries (2005 - 2020)” to be held on November 23, 2011
Analyst Briefing Presentation on the “Lung Cancer Drugs Market in G7 Countries (2005 - 2020)” to be held on November 23, 2011
The “Healthcare” practice at MarketsandMarkets is pleased to announce its “Analyst Briefing Presentation” on the “Lung Cancer Drugs Market in G7 Countries (2005 - 2020)” to be held on November 23, 2011.
The lung cancer drugs market is expected to grow at a CAGR of 13.5% from 2015 to 2020. The market was dominated by drugs such as Avastin, Iressa, Gemzar, and Tarceva in 2010. However, by 2020; the market is expected to be dominated by talactoferrin (Agennix), an immunomodulatory drug followed by Xalkori (Pfizer), and by ARQ 197 (ArQule/Daiichi Sankyo). Pipeline drugs and increasing lung cancer population in the G7 countries are the major factors driving the market for new drugs. A potential limiting factor in the growth of sales for lung cancer drugs will be the major drugs going off-patent during the time period being forecasted.
From a regional approach, North America accounts for the largest lung cancer population globally. The incidence has noticed a steady decline in the past decade. Newly diagnosed cases declined by 0.8% between 2003 and 2007. The death rates in women have declined by 1% during the same period in comparison with an annual increase of 6% in 1970’s.
Major players in the market include F. Hoffmann-La Roche Ltd (Switzerland), AstraZeneca Plc (U.K.), Eli Lilly and Company (U.S.), Sanofi-Aventis (France), Pfizer Inc. (U.S.), GlaxoSmithKline Pharmaceuticals Limited (U.K.), ArQule Inc. (U.S.), Daiichi Sankyo Co. Ltd. (Japan), Agennix AG (Germany), and Boehringer Ingelheim GmbH (Germany).
About MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.
MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website www.marketsandmarkets.com
Note: An email containing the Login Details and Time of the Analyst Briefing will be sent to you soon after your registration.
